Robuta

https://www.techtransfer.nih.gov/patent/e-100-1989-0-at-16 Stabilized Nitric Oxide-Primary Amine Complexes Useful as Cardiovascular Agents | Technology... nitric oxide primary amine cardiovascular agents stabilized https://www.techtransfer.nih.gov/patent/e-100-1989-0-ep-06 Stabilized Nitric Oxide-Primary Amine Complexes Useful as Cardiovascular Agents | Technology... nitric oxide primary amine cardiovascular agents stabilized https://www.techtransfer.nih.gov/patent/e-100-1989-0-nl-12 Stabilized Nitric Oxide-Primary Amine Complexes Useful as Cardiovascular Agents | Technology... nitric oxide primary amine cardiovascular agents stabilized https://pubmed.ncbi.nlm.nih.gov/26876916/ Therapeutic potential of chalcones as cardiovascular agents Cardiovascular diseases are the leading cause of death affecting 17.3 million people across the globe and are estimated to affect 23.3 million people by year... therapeutic potential chalcones cardiovascular agents https://www.techtransfer.nih.gov/patent/e-074-1992-0-au-05 MIXED LIGAND METAL COMPLEXES OF NITRIC OXIDE NUCLEOPHILE ADDUCTS USEFUL AS CARDIOVASCULAR AGENTS |... https://www.techtransfer.nih.gov/patent/e-059-1986-1-us-03 ADENOSINE FUNCTIONALIZED CONGENERS AS CARDIOVASCULAR TREATING AGENTS FOR ANIMALS | Technology... for animals adenosine functionalized cardiovascular treating https://pubmed.ncbi.nlm.nih.gov/38379024/ New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023 Although cardiovascular diseases (CVDs) are the leading cause of death worldwide, their pharmacotherapy remains suboptimal. Thus, there is a clear unmet need... new pharmacological agents novel cardiovascular https://www.techtransfer.nih.gov/patent/e-074-1992-0-ca-06 MIXED LIGAND METAL COMPLEXES OF NITRIC OXIDE NUCLEOPHILE ADDUCTS USEFUL AS CARDIOVASCULAR AGENTS |... https://www.techtransfer.nih.gov/patent/e-074-1992-0-jp-13 MIXED LIGAND METAL COMPLEXES OF NITRIC OXIDE NUCLEOPHILE ADDUCTS USEFUL AS CARDIOVASCULAR AGENTS |...